Your session is about to expire
Erythromycin vs Azithromycin
Introduction
For patients suffering from bacterial infections, certain antibiotics can help combat these invading microorganisms. Erythromycin and Azithromycin are two such drugs that belong to the macrolide group of antibiotics. These drugs function by inhibiting protein synthesis in bacteria, thereby curbing their growth and propagation. Erythromycin is a broad-spectrum antibiotic that is effective against a wide variety of bacteria including Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and others. On the other hand, Azithromycin also covers an extensive range of pathogens but has an extended half-life which allows for once daily dosing and shorter therapy courses. It's important to note that both medications may cause side effects such as nausea, vomiting or abdominal pain among others.
Erythromycin vs Azithromycin Side By Side
| Attribute | Erythrocin e mycin | Zithromax z pak |
|---|---|---|
| Brand Name | Erythrocin, E-Mycin | Zithromax, Z-Pak |
| Contraindications | Should not be taken with certain medications like statins for high cholesterol levels or blood thinners due to potential for harmful drug interactions. Serious interactions with certain heart rhythm drugs. | Should not be taken with certain medications like statins for high cholesterol levels or blood thinners due to potential for harmful drug interactions. Serious interactions with certain heart rhythm drugs. |
| Cost | For brand name: around $600 for 60 tablets of 250 mg. Generic: $0.50 to $1.50 per tablet. | For brand name: approximately $30 for six tablets of 250 mg. Generic: roughly $0.40 to just over one dollar per tablet. |
| Generic Name | Erythromycin | Azithromycin |
| Most Serious Side Effect | Severe allergic reactions, liver problems, heart issues, severe skin reaction. | Severe allergic reaction, severe skin reaction, serious liver problems, fast or irregular heartbeats. |
| Severe Drug Interactions | Can have serious interactions with certain heart rhythm drugs, leading to dangerous cardiac rhythm abnormalities. | Can have serious interactions with certain heart rhythm drugs, leading to dangerous cardiac rhythm abnormalities. |
| Typical Dose | 250-500 mg every 6 hours, or 500-1000 mg every 12 hours. | 500 mg on the first day, followed by 250 mg once daily for the next four days. |
What is Erythromycin?
Erythromycin, the first antibiotic from the macrolide group, marked a significant advance over penicillin and other earlier antibiotics. It was first approved by the FDA in 1952. Erythromycin works by inhibiting protein synthesis of bacteria, effectively limiting their growth and reproduction capabilities. It is prescribed for treatment of various bacterial infections including respiratory tract infections, skin infections and sexually transmitted diseases among others. Erythromycin has a broad spectrum of activity with major influence on gram-positive bacteria but minor influence on gram-negative bacteria which results in it having fewer side effects than other antibiotics that have stronger effects on these two types of bacteria.
In contrast to erythromycin's short half-life requiring multiple doses per day, azithromycin offers an extended-release formulation providing prolonged coverage with less frequent dosing. Azithromycin concentrates more efficiently within cells where pathogens often reside rather than floating freely in the bloodstream thus making it ideal for treating intracellular organisms like Legionella or Chlamydia species.
What conditions is Erythromycin approved to treat?
Erythromycin and Azithromycin are both authorized for the treatment of a variety of bacterial infections, including:
- Various respiratory tract infections such as pneumonia, whooping cough (pertussis), and Legionnaires' disease.
- STIs like chlamydia and gonorrhea
- Skin infections like acne or impetigo
- Some types of stomach conditions related to certain bacteria (like Helicobacter pylori).
It's important to note that while they're used to treat similar conditions, these two medications belong to different classes - Erythromycin is a macrolide antibiotic while Azithromycin is an azalide, a subclass of macrolide antibiotics.
How does Erythromycin help with these illnesses?
Erythromycin works to fight bacterial infections by inhibiting the synthesis of essential proteins needed for bacterial growth. It does this by binding to a part of the ribosome in the bacteria, thus preventing protein production and consequently stunting the bacteria's ability to grow and reproduce. This property makes it an effective agent against a wide range of bacteria including Streptococcus, Staphylococcus, and Haemophilus influenzae among others.
Similarly, Azithromycin also fights against bacterial infections but with a longer half-life than Erythromycin. This means that it stays in your system for a longer period after dosage which allows for less frequent dosing (usually once daily) compared with erythromycin (typically four times daily). Like Erythromycin, Azithromycin also binds to the bacterial ribosome hindering protein synthesis but due its structural differences has shown increased effectiveness against certain types of bacteria such as Chlamydophila pneumoniae and Mycoplasma pneumoniae which are usually resistant to Erythromycin.
What is Azithromycin?
Azithromycin is a broad-spectrum macrolide antibiotic that was first approved by the FDA in 1991. Like erythromycin, it works by inhibiting bacterial protein synthesis, but due to its chemical structure, azithromycin has a longer half-life and reaches higher concentrations in tissues than erythromycin. This allows for once-daily dosing and a shorter treatment duration compared to other antibiotics.
While both azithromycin and erythromycin can be used to treat similar bacterial infections, the side effect profiles of the two drugs are different. Azithromycin tends not to cause as many gastrointestinal side effects like nausea or diarrhea as erythromycin does. It also doesn't interact with certain heart medications the way that erythromycin can.
In general, azithromycin is often preferred over erythromium because of its more convenient dosing schedule and better tolerability among patients. However, it's important for patients to discuss their specific needs and health circumstances with their healthcare provider before starting any new medication.
What conditions is Azithromycin approved to treat?
Azithromycin is a broad-spectrum antibiotic, approved for the treatment of several types of bacterial infections including:
- Various types of skin infections
- Respiratory tract infections such as pneumonia and bronchitis
- Sinusitis and severe ear infections
- Certain sexually transmitted diseases like Chlamydia and Gonorrhea.
How does Azithromycin help with these illnesses?
Azithromycin, like erythromycin, is a type of antibiotic known as a macrolide. It works by inhibiting protein synthesis in bacteria, thereby preventing their growth and proliferation. However, azithromycin has several advantages over erythromycin that can make it the preferred choice for some patients. Firstly, it has a longer half-life than erythromycin which allows for once-daily dosing; this improved convenience can enhance patient compliance with treatment. Secondly, azithromycin tends to cause fewer gastrointestinal side effects compared to erythromycin - something many patients appreciate. Finally, while both antibiotics are generally effective against similar types of bacteria (such as Streptococcus pneumoniae and Haemophilus influenzae), azithromycin is often chosen due to its better tissue penetration and higher resistance to stomach acid.
How effective are both Erythromycin and Azithromycin?
Both erythromycin and azithromycin belong to the macrolide family of antibiotics with proven histories of combating bacterial infections. Erythromycin was approved by the FDA in 1967, while azithromycin got its approval in 1991.
In a comparative study conducted in 2002, both drugs showed similar efficacy levels when treating community-acquired pneumonia. However, patients treated with azithromycin demonstrated quicker symptom resolution without any significant difference in side effects compared to those given erythromycin.
A systematic review from 2000 confirmed that erythromycin effectively treats respiratory tract infections, skin and soft tissue infections. The review also noted that it is generally well-tolerated but may cause gastrointestinal upset more frequently than some other antibiotics. As one of the first macrolides developed, there's been substantial research confirming its effectiveness as an antibiotic agent.
On the other hand, a meta-analysis published in 2015 found that azithromycin is effective for treating sinusitis and bronchitis and appears to have less risk for causing serious cardiac events versus several comparator drugs including levofloxacin or amoxicillin/clavulanate. Azithromycin's long half-life allows for shorter therapy duration (typically five days) which can improve patient compliance rates compared to longer regimens required by many other antibiotics like erythromycin.
Despite these facts, choice between these two medications often depends on specific patient factors such as drug allergies or intolerances (e.g., gastrointestinal adverse effects), potential drug-drug interactions since both interact differently with various co-prescribed medications; types of infection being treated because certain bacteria are more susceptible to one over another; local resistance patterns; along with considerations related to dosing frequency where once-daily dosing regimen offered by azithyomcin might be advantageous especially among pediatric population or those having difficulty adhering medication schedules due better convenience over typically four times daily dosage schedule prescribed for eryhtrmycin which could prove cumbersome for many patients thereby affecting overall treatment outcome negatively due poor adherence rates associated increased dosage frequencies+
Related trials for erythromycin and azithromycin
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Erythromycin typically prescribed?
Oral dosages of Erythromycin range from 250-500 mg every 6 hours, or 500-1000 mg every 12 hours. In children, the dose is typically determined by their body weight and severity of infection. On the other hand, Azithromycin may be administered as a single daily dose over a relatively short treatment period. It's often given at doses of 250 to 500mg/day for adults, and in children it's based on body weight (10mg/kg). Dosage can be adjusted depending on the severity of the infection but should not exceed adult dosage even in adolescents. The maximum recommended duration for Azithromycin is usually five days.
At what dose is Azithromycin typically prescribed?
Azithromycin treatment is commonly initiated at a dosage of 500 mg on the first day, followed by 250 mg once daily for the next four days. This forms what is typically known as a "Z-Pak", or five-day course of therapy. For certain conditions like community-acquired pneumonia and pelvic inflammatory disease, the dose may be increased to 500mg each day for all five days. If there's no response after this period, your healthcare provider might consider a different antibiotic or testing for resistance patterns in the infective organism. The ease of dosing with azithromycin lies in its once-daily administration and shorter duration compared to other antibiotics, which often require multiple doses per day over an extended period.
What are the most common side effects for Erythromycin?
When comparing Erythromycin to Azithromycin, here are some common side effects you may experience:
- Nausea and vomiting
- Diarrhea or loose stools
- Abdominal discomfort (stomach cramps)
- Loss of appetite
- Headache
- Dizziness
- Mild skin rash
- Vaginal itching or discharge in women Please note that severe side effects can occur as well. These include liver problems, heart issues such as palpitations or chest pain, allergic reactions with symptoms like hives, difficulty breathing and swelling of your face/lips/tongue/throat. If any of these severe symptoms occur seek medical attention immediately.
Are there any potential serious side effects for Erythromycin?
While Erythromycin and Azithromycin are both antibiotics used to treat various infections, they can have different side effects:
- Severe allergic reactions: These could include a rash, difficulty breathing, swelling of your face or throat
- Liver problems: Symptoms might be nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools or jaundice (yellowing of the skin or eyes)
- Heart issues: Some patients may experience chest pain spreading to your jaw or shoulder; severe dizziness; rapid heartbeats
- Diarrhea that is watery or bloody (which may occur even months after your last dose)
- Severe skin reaction - fever; sore throat; burning in your eyes; skin pain followed by a red or purple skin rash that spreads and causes blistering and peeling If you experience any of these symptoms while taking either medication contact healthcare provider immediately.
What are the most common side effects for Azithromycin?
Azithromycin, while generally well-tolerated, can cause some side effects:
- Stomach upset, nausea or vomiting
- Diarrhea,
- Mild skin rash
- Headache or dizziness
- Abnormal taste sensation (dysgeusia)
- Sleep problems (insomnia) It's also worth noting that Azithromycin may potentially cause a fast or irregular heartbeat in rare cases. If you experience severe symptoms like muscle weakness or chest pain after taking Azithromycin, it is essential to seek immediate medical attention.
Are there any potential serious side effects for Azithromycin?
Azithromycin, while generally considered safe and effective, can in rare instances trigger serious side effects. Be on the lookout for indications of such adverse reactions including:
- Signs of an allergic reaction, such as hives; difficulty breathing; swelling in your face or throat
- Severe skin reaction: fever, sore throat, burning eyes, skin pain
- A red or purple skin rash that spreads (especially in the face or upper body) causing blistering and peeling
- Serious liver problems - nausea, upper stomach pain, itching, tiredness loss of appetite
- Dark urine clay-colored stools jaundice (yellowing of the skin or eyes)
- Fast or irregular heartbeats: chest fluttering sensation shortness breath sudden dizziness fainting.
If you notice any of these symptoms after taking azithromycin stop using it immediately and seek medical attention.
Contraindications for Erythromycin and Azithromycin?
Erythromycin and Azithromycin, similar to other antibiotics, may cause digestive issues such as nausea or diarrhea in some individuals. If you notice these symptoms worsening significantly, please seek immediate medical attention.
Neither Erythromycin nor Azithromycin should be taken if you are taking certain medications like statins for high cholesterol levels or blood thinners due to the potential for harmful drug interactions. Always inform your physician about all the medications you are currently taking; if there's a need to take any of these antibiotics while on other medication, it might require careful dose adjustment and close monitoring by your doctor.
Furthermore, both erythromycin and azithromycin can have serious interactions with certain heart rhythm drugs. The combination could lead to dangerous cardiac rhythm abnormalities. Therefore, patients who are prescribed drugs known as QT-prolonging agents should use caution when considering treatment with either erythromycin or azithromycin.
How much do Erythromycin and Azithromycin cost?
For the brand name versions of these drugs:
- The price for 60 tablets of Erythromycin (250 mg) averages around $600, which works out to about $10/day.
- The cost for six tablets of Azithromycin (250 mg), often taken as a single course treatment, is approximately $30. This equates to about $5 per day during the typical five-day treatment period.
Thus, if you are taking erythromycin at higher dosages (i.e., 1000 mg/day or more), then a single course of brand-name azithromycin could be less expensive on a per-day basis. However, please note that cost should not be your primary consideration in determining which antibiotic is right for you.
For generic versions of both antibiotics:
- Generic erythromycin costs range from about $0.50 to $1.50 per tablet depending on dosage and location.
- Generic azithromycin ranges from roughly $0.40 to just over one dollar per tablet.
As always, prices can vary based on factors such as pharmacy location and insurance coverage.
Popularity of Erythromycin and Azithromycin
Erythromycin, including brand versions such as Erythrocin and E-Mycin, was estimated to have been prescribed to about 2.3 million people in the US in 2020. It is a macrolide antibiotic that has been used for decades to treat various types of bacterial infections. Although it accounted for just under 7% of all antibiotic prescriptions last year, erythromycin still plays a crucial role in treating specific conditions like whooping cough and gastroparesis.
Azithromycin, also known by its brand name Zithromax or “Z-Pak”, had an even broader reach with approximately 16 million prescriptions filled across the United States in 2020. Azithromycin accounts for over half of all macrolide antibiotic prescriptions dispensed within this period which represents nearly a quarter of overall antibiotics prescribed. Its popularity can be attributed partly to its convenient dosing schedule (often only five days) and broad-spectrum activity against numerous bacteria. The usage rate of azithromycin has remained relatively steady over the past decade.
Conclusion
Both erythromycin and azithromycin are antibiotics belonging to the macrolide group, with a long-standing record of usage in treating bacterial infections. They work by inhibiting protein synthesis in bacteria, thereby stopping their growth or killing them outright. Due to their different pharmacokinetic properties and side effect profiles, they tend to be prescribed under different circumstances.
Erythromycin is typically administered more frequently (usually four times daily), while azithromycin's longer half-life allows for once-daily dosing or even a short 3-5 day course of therapy for some conditions. This can enhance patient compliance leading to better treatment outcomes.
Both drugs are available as generics, providing cost-effective options for patients. The use of either medication may require an adjustment period as the body acclimates to its effects on gut flora which can lead initially to gastrointestinal discomfort. The side effect profile differs slightly between these two agents; both are generally well-tolerated but erythromycin is more likely than azithromycin to cause gastrointestinal upset such as nausea or diarrhea due mainly due its direct stimulatory effect on gut motility.
In all cases where antibiotics like erythroymcin and azithyomcin are prescribed, it's important that patients take the full course of therapy unless directed otherwise by their healthcare provider even if symptoms improve before completion - this helps prevent development of antibiotic resistance among surviving bacteria.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014, August). Azithromycin: Mechanisms of action and their relevance for clinical applications. Pharmacology & Therapeutics. Elsevier BV.http://doi.org/10.1016/j.pharmthera.2014.03.003
- Brittain, D. C. (1987, November). Erythromycin. Medical Clinics of North America. Elsevier BV.http://doi.org/10.1016/s0025-7125(16)30802-1
- Amsden, G. (1996, February). Erythromycin, clarithromycin, and azithromycin: are the differences real?. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/s0149-2918(96)80179-2
- PRESTON, D. A. (1986, January). Microbiological aspects of erythromycin. The Pediatric Infectious Disease Journal. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/00006454-198601000-00045
- McCarty, J. M. (1996, January). Azithromycin (Zithromax <sup>®</sup>). Infectious Diseases in Obstetrics and Gynecology. Wiley.http://doi.org/10.1155/s1064744996000415
- Duran, J. M., & Amsden, G. W. (2000, March). Azithromycin: indications for the future?. Expert Opinion on Pharmacotherapy. Informa UK Limited.http://doi.org/10.1517/14656566.1.3.489
- Champney, W. S., & Miller, M. (2002, June). Inhibition of 50S Ribosomal Subunit Assembly in Haemophilus influenzae Cells by Azithromycin and Erythromycin. Current Microbiology. Springer Science and Business Media LLC.http://doi.org/10.1007/s00284-001-0016-6
- Vergis, E. N., Indorf, A., File, T. M., Phillips, J., Bates, J., Tan, J., … Yu, V. L. (2000, May 8). Azithromycin vs Cefuroxime Plus Erythromycin for Empirical Treatment of Community-Acquired Pneumonia in Hospitalized Patients. Archives of Internal Medicine. American Medical Association (AMA).http://doi.org/10.1001/archinte.160.9.1294
- COHEN, R. (2004, February). Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Pediatric Infectious Disease Journal. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/01.inf.0000112527.33870.0d
- Treadway, G., & Pontani, D. (1996, June 1). Paediatric safety of azithromycin: worldwide experience. Journal of Antimicrobial Chemotherapy. Oxford University Press (OUP).http://doi.org/10.1093/jac/37.suppl_c.143
- Lockwood, A. M., Cole, S., & Rabinovich, M. (2010, May 15). Azithromycin-induced liver injury. American Journal of Health-System Pharmacy. Oxford University Press (OUP).http://doi.org/10.2146/ajhp080687
- Abu Mellal, A., Hussain, N., & Said, A. (2019, July). <p>The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies</p>. Therapeutics and Clinical Risk Management. Informa UK Limited.http://doi.org/10.2147/tcrm.s214938
- Howard, K. B., Blumenschein, K., & Rapp, R. P. (1999, August 1). Azithromycin versus erythromycin for community-acquired pneumonia: A cost-minimization analysis. American Journal of Health-System Pharmacy. Oxford University Press (OUP).http://doi.org/10.1093/ajhp/56.15.1521